You are here: Welcome » Laura Sauvé

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Both sides next revision
laura_sauve [2023/02/02 07:21]
liam [COVID-19]
laura_sauve [2023/02/02 07:21] (current)
liam [COVID-19]
Line 21: Line 21:
 ==== COVID-19 ==== ==== COVID-19 ====
  
-Sauvé is the pediatric representative to the Clinical Research Group at the [[British Columbia Centre for Disease Control]] (BCCDC) which leads review of all provincial [[COVID-19]] guidelines, and the chair of the [[Canadian Paediatric Society]]’s Committee on Infectious Diseases and Immunization.+Sauvé is the pediatric representative to the Clinical Research Group at the [[BC Centre for Disease Control]] (BCCDC) which leads review of all provincial [[COVID-19]] guidelines, and the chair of the [[Canadian Paediatric Society]]’s Committee on Infectious Diseases and Immunization.
  
 {{ youtube>E-VaKNH3aMM?}} {{ youtube>E-VaKNH3aMM?}}
  
 On March 9, 2022, a video featuring Sauvé was uploaded to a [[YouTube]] channel called [[Healthy Canadians]], run by the [[Government of Canada]].((Health Canada. (2022, October 28). //Ask the experts COVID-19 vaccines questions: Safety, ingredients and side effects.// Government of Canada. https://www.canada.ca/en/health-canada/services/video/ask-experts-covid-19-vaccines.html)) In the video, she downplays the risks of adverse events following injection of children, specifically omitting every severe adverse event. On March 9, 2022, a video featuring Sauvé was uploaded to a [[YouTube]] channel called [[Healthy Canadians]], run by the [[Government of Canada]].((Health Canada. (2022, October 28). //Ask the experts COVID-19 vaccines questions: Safety, ingredients and side effects.// Government of Canada. https://www.canada.ca/en/health-canada/services/video/ask-experts-covid-19-vaccines.html)) In the video, she downplays the risks of adverse events following injection of children, specifically omitting every severe adverse event.
Back to top